LINDSEY MYERS: Open Payments
NPI 1588401038 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 34 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $652 · 2025 $1,530
Travel & lodging: $831Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $831 |
| AstraZeneca Pharmaceuticals LP | 4 | $154 |
| ABIOMED | 2 | $104 |
| Novo Nordisk Inc | 5 | $80 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $73 |
| Astellas Pharma US Inc | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $40 |
| Exact Sciences Corporation | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: FARXIGA, LifeVest, Veozah, Auvelity, VRAYLAR, Cologuard Collection Kit, Rybelsus, BREZTRI.
Industry payments across IN — which companies pay providers there.
